|
Wu Q, Wu Y, Zhang Y, Guan Y, Huang G, Xie F, Liu J, Zhai W,
|
ImmunoPET/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2024
|
https://doi.org/10.1007/s00259-024-06672-3
|
|
Huang W, Liang C, Zhang Y, Zhang D, An S, Wu Q, Li J, Zhao H, Wang C, Cui J, Bao Z, Huang G,, Liu J
|
ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2024
|
51(2):380-394.
|
|
Huang W, Zhang Y, Cao M, Wu Y, Jiao F, Chu Z, Zhou X, Li L, Xu D, Pan X, Guan Y, Huang G, Liu J, Xie F,
|
ImmunoPET imaging of Trop2 in patients with solid tumours
|
EMBO Molecular Medicine
|
2024
|
https://doi.org/10.1038/s44321-024-00059-5.
|
|
Zhang Y, Cao M, Wu Y, Malih S, Xu D, Yang E, Younis MH, Lin W, Zhao H, Wang C, Liu Q, Engle JW, Rasaee MJ, Guan Y, Huang G, Liu J, Cai W, Xie F,
|
Preclinical development of novel PD-L1 tracers and first-in-human study of [68Ga]Ga-NOTA-RW102 in patients with lung cancers
|
Journal for ImmunoTherapy of Cancer
|
2024
|
12(4):e008794.
|
|
Li X, Younis MH,, Cai W*.
|
PD-L1 - targeted magnetic fluorescent hybrid nanoparticles: Illuminating the path of image-guided cancer immunotherapy.
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2023
|
50(8):2240-2243.
|
|
|
Theranostics Is Not Radiotheranostics
|
Journal of Nuclear Medicine
|
2023
|
1;64(12):2002.
|
|
Liang C, Huang W, Zhang Y, Zhang D, An S, Wu Q, Zhao H, Wang C, Huang G,, Liu J
|
ImmunoPET Imaging of CD47 with VHH-Derived Tracers in Pancreatic Cancers
|
Molecular Pharmaceutics
|
2023
|
20(8):4184-4195.
|
|
An S, Liu J, Huang G, Kang F,
|
PET imaging of tumor vascular normalization in hepatocellular carcinoma
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2023
|
20(8):4184-4195.
|
|
Dawei Jiang,
|
Molecular imaging for better theranostics
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2023
|
50(13):3799-3801.
|
|
Song W,, Lan X, Cai W.
|
Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2023
|
50(9):2591-2594.
|
|
Wei Huang, Yizhen Pang, Qiufang Liu, Chenyi Liang, Shuxian An, Qianyun Wu, You Zhang, Gang Huang, Haojun Chen, Jianjun Liu,
|
Development and Characterization of Novel FAP-Targeted Theranostic Pairs: A Bench-to-Bedside Study
|
Research (Wash D C)
|
2023
|
6(9): 0282.
|
|
Siyu Zhou, Xiaofeng Fang, Jiahui Lv, Yicheng Yang, Yiqi Zeng, Ying Liu ,, Gang Huang, Bo Zhang, Changfeng Wu
|
Site-Specific Modification of Single Domain Antibodies by Enzyme-Immobilized Magnetic Beads
|
Bioconjugate Chemistry
|
2023
|
34(10):1914-1922.
|
|
Zhang Y, Zhang D, An S, Liu Q, Liang C, Li J, Liu P, Wu C, Huang G*,, Liu J*.
|
Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors
|
Research (Wash D C)
|
2023
|
2023;6:0077.
|
|
, Zhang D, Zhang Y, Li L, Jin Y, An S, Lv C, Zhao H, Wang C, Huang Y, Dong J, Huang G*, Liu J*.
|
Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2.
|
Molecular Therapy Oncolytics
|
2022
|
14;27:305-314
|
|
,#, Zhang Y#, Zhang D, Liu Q, An S, Chen Y, Huang G, Liu J*.
|
Annotating BCMA Expression in Multiple Myelomas
|
Molecular Pharmaceutics
|
2022
|
19(10):3492-3501
|
|
, Younis MH, Lan X, Liu J, Cai W.
|
Single-Domain Antibody Theranostics on the Horizon
|
Journal of Nuclear Medicine
|
2022
|
63(10):1475-1479
|
|
Shuxian An, Di Zhang , You Zhang, Cheng Wang, Liang Shi,, Gang Huang, Jianjun Liu.
|
GPC3-targeted immunoPET imaging of hepatocellular carcinomas
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2022
|
49(8):2682-2692
|
|
Xie F,
|
[64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2022
|
49(12):3964-3972
|
|
, Zhang D#, Wang C, Zhang Y, An S, Chen Y, Huang G, Liu J*
|
Annotating CD38 Expression in Multiple Myeloma with [18F]F-Nb1053
|
Molecular Pharmaceutics
|
2022
|
19(10):3502-3510
|
|
Yang E, Liu Q, Huang G, Liu J*,
|
Engineering nanobodies for next-generation molecular imaging
|
Drug Discovery Today
|
2022
|
27(6):1622-1638
|
|
An S, Huang G, Liu J,
|
PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2022
|
49(12):3973-3976
|
|
Wang Q, Zhang X,, Cao M*.
|
PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective
|
Molecular Pharmaceutics
|
2022
|
19(10):3471-3483
|
|
, Jiang D, Evangelista L, Cai W.
|
Antibody-Based Imaging and Therapy for Precision Medicine
|
Molecular Pharmaceutics
|
2022
|
19(10):3453-3455
|
|
Wu Q, Huang G,, Liu J*.
|
Molecular Imaging of Renal Cell Carcinoma in Precision Medicine
|
Molecular Pharmaceutics
|
2022
|
19(10):3457-3470
|
|
Jin Y#, Liu B#, Younis MH, Huang G, Liu J, Cai W*,
|
Next-Generation Molecular Imaging of Thyroid Cancer
|
Cancers (Basel)
|
2021
|
13(13):3188
|
|
Cheng Wang#, Yumei Chen#, Yun Nan Hou, Qiufang Liu , Di Zhang , Haitao Zhao , You Zhang , Shuxian An, Lianghua Li, Jian Hou , Gang Huang, Jianjun Liu*, Yong Juan Zhao*,
|
ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2021
|
48(9):2749-2760
|
|
Dun Y, Huang G, Liu J*,
|
ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical reality
|
Drug Discovery Today
|
2021
|
S1359-6446(21)00500-6
|
|
Miao Li#,, Todd E Barnhart, Dawei Jiang, Tianye Cao, Kevin Fan, Jonathan W Engle, Jianjun Liu, Weiyu Chen, Weibo Cai.
|
ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2021
|
48(9):2737-2748
|
|
, Rosenkrans ZT, Liu J, Huang G*, Luo Q-Y*, Cai W*.
|
ImmunoPET: Concept, Design, and Applications
|
Chemical Reviews
|
2020
|
120(8):3787-3851
|
|
, Dawei Jiang , Hye Jin Lee , Jonathan W Engle , Hisaya Akiba , Jianjun Liu , Weibo Cai
|
ImmunoPET Imaging of TIM-3 in Murine Melanoma Models
|
Advanced Therapeutics
|
2020
|
3(7):2000018
|
|
, Liu Q#, Jiang D, Zhao H, Kutyreff CJ, Engle JW, Liu J*, Cai W*
|
Tissue Factor-Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
|
Advanced Science
|
2020
|
7(13):1903595
|
|
, Jiang D#, Lee HJ, Li M, Kutyreff CJ, Engle JW, Liu J*, Cai W*
|
Development and characterization of CD54-targeted immunoPET imaging in solid tumors
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2020
|
47(12):2765-2775
|
|
, Ehlerding EB#, Lan X*, Luo Q*, Cai W*
|
Molecular imaging of β-cells: diabetes and beyond
|
Advanced Drug Delivery Reviews
|
2019
|
2019;139:16-31
|
|
, Hardin H, Luo QY
|
Targeting Autophagy in Thyroid Cancers
|
Endocrine-Related Cancer
|
2019
|
26(4):R181-R194
|
|
, Jiang D#, Ehlerding EB, Barnhart TE, Yang Y, Engle JW, Luo QY*, Huang P*, Cai W*
|
CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma
|
Advanced Science
|
2019
|
6(9):1801237
|
|
, Jiang D, Rosenkrans ZT, Barnhart TE, Engle JW, Luo Q, Cai W.
|
HER2-targeted multimodal imaging of anaplastic thyroid cancer
|
American Journal of Cancer Research
|
2019
|
9(11):2413-2427
|
|
, Rosenkrans ZT, Luo QY#, Lan X#, Cai W#
|
Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy
|
Small Methods
|
2018
|
3(2):1800365.
|
|
, Jiang D#, Ehlerding EB, Luo Q*, Cai W*
|
Noninvasive PET Imaging of T cells
|
Trends in Cancer
|
2018
|
4(5):359-373
|
|
, Ehlerding EB#, Lan X*, Luo Q*, Cai W*
|
PET and SPECT imaging of melanoma: the state of the art
|
European Journal of Nuclear Medicine and Molecular Imaging
|
2018
|
45(1):132-150
|
|
, Ni D#, Ehlerding EB, Luo QY*, Cai W*
|
PET imaging of receptor tyrosine kinases in cancer
|
Molecular Cancer Therapeutics
|
2018
|
17(8):1625-1636
|
|
, Zhang GQ*, Luo QY.
|
Postsurgical Management of Differentiated Thyroid Cancer in China
|
Trends in Endocrinology & Metabolism
|
2018
|
29(2):71-73
|
|
, Sun ZK#, Shen CT, Song HJ, Zhang XY, Qiu ZL*, Luo QY*.
|
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
|
Theranostics
|
2017
|
7(4):987-1001
|
|
, Sun ZK, Shen CT, Qiu ZL, Luo QY*
|
Adefovir-Induced Hypophosphatemic Osteomalacia Mimicking Bone Metastases From Primary Hepatocarcinoma
|
Clinical Nuclear Medicine
|
2017
|
42(9):e405-e406
|
|
, Shen CT, Song HJ, Qiu ZL, Luo QY*
|
Metastatic malignant fibrous histiocytoma infiltrating sigmoid colon: A Case diagnosed with the help of 18F-FDG PET/CT
|
Clinical Nuclear Medicine
|
2016
|
41(4):338-40
|